Cetuximab - HY-P9905
Nur noch %1 verfügbar
Catalog #
HY-P9905
Ab
248,00 €
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P9905/Cetuximab-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-Kinase/protease |
| Alternative Names | C225; IMC-C225 |
| CAS | 205923-56-4 |
| Storage | Store at 4°C for 2 years, do not freeze |
| MWT | (145.54 kDa) |
| Solubility | H2O |
| Clinical Information | Launched |
| Target | EGFR;Radionuclide-Drug Conjugates (RDCs) |
| Application: | Cancer-Kinase/protease |
|---|